Recognising increased risk of melanoma
Mass screening is not cost-effective, but effort should be made to identify patients at high risk. By Dr Joy Osborne
To continue enjoying this article, please sign in. You can register for free for limited further access, or subscribe now for full access to all our content. View our subscription and registration options.